Literature DB >> 8506276

Transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.

T Sasaoka1, Y Takata, J Kusari, C M Anderson, W J Langlois, J M Olefsky.   

Abstract

To assess the function of the cytoplasmic domain of the insulin receptor (IR) beta subunit, we have studied a mutant IR truncated by 365 aa (HIR delta 978), thereby deleting > 90% of the cytoplasmic domain. HIR delta 978 receptors were processed normally to homodimers that were expressed at the cell surface where they bind insulin with normal affinity. Although these truncated IRs were inactive with respect to ligand-induced internalization and autophosphorylation, insulin stimulated endogenous substrate (pp185) phosphorylation significantly more in HIR delta 978 cells than in untransfected Rat1 cells. Importantly, despite absence of the beta-subunit cytoplasmic domain, fibroblasts expressing HIR delta 978 receptors displayed enhanced sensitivity to insulin for stimulation of glucose incorporation into glycogen, alpha-aminoisobutyric acid uptake, thymidine incorporation, and S6 kinase activity compared with parental fibroblasts. Insulin also induced the expression of the protooncogene c-fos and the early growth response gene Egr-1 in HIR delta 978 cells far greater than in parental Rat1 fibroblasts. Furthermore, an agonistic monoclonal antibody specific for the human IR stimulated insulin action in fibroblasts expressing wild-type human IR but had no effect on HIR delta 978 cells. In conclusion, the HIR delta 978 truncated IRs appear to confer enhanced insulin sensitivity by augmenting the signaling properties of the endogenous rodent IRs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506276      PMCID: PMC46514          DOI: 10.1073/pnas.90.10.4379

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Intracellular signaling by a mutant human insulin receptor lacking the carboxyl-terminal tyrosine autophosphorylation sites.

Authors:  Y Takata; N J Webster; J M Olefsky
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

2.  Monoclonal antibodies as probes of the structure and function of insulin receptors.

Authors:  K Siddle; M A Soos; R M O'Brien; R H Ganderton; R Taylor
Journal:  Biochem Soc Trans       Date:  1987-02       Impact factor: 5.407

3.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

4.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

Authors:  C K Chou; T J Dull; D S Russell; R Gherzi; D Lebwohl; A Ullrich; O M Rosen
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

5.  Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.

Authors:  Y Ebina; E Araki; M Taira; F Shimada; M Mori; C S Craik; K Siddle; S B Pierce; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Metabolism of photoaffinity-labeled insulin receptors by adipocytes. Role of internalization, degradation, and recycling.

Authors:  K A Heidenreich; D Brandenburg; P Berhanu; J M Olefsky
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

7.  Insulin and growth factor effects on c-fos expression in normal and protein kinase C-deficient 3T3-L1 fibroblasts and adipocytes.

Authors:  D J Stumpo; P J Blackshear
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  In vitro deletional mutagenesis for bacterial production of the 20,000-dalton form of human pituitary growth hormone.

Authors:  J P Adelman; J S Hayflick; M Vasser; P H Seeburg
Journal:  DNA       Date:  1983
View more
  3 in total

1.  Insulin augments GnRH-stimulated LHbeta gene expression by Egr-1.

Authors:  Colleen Buggs; Frank Weinberg; Ellen Kim; Andrew Wolfe; Sally Radovick; Fredric Wondisford
Journal:  Mol Cell Endocrinol       Date:  2006-03-10       Impact factor: 4.102

2.  Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors.

Authors:  R R Flörke; K Schnaith; W Passlack; M Wichert; L Kuehn; M Fabry; M Federwisch; H Reinauer
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

3.  Tyrosine kinase-deficient mutant human insulin receptors (Met1153-->Ile) overexpressed in transfected rat adipose cells fail to mediate translocation of epitope-tagged GLUT4.

Authors:  M J Quon; M Guerre-Millo; M J Zarnowski; A J Butte; M Em; S W Cushman; S I Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.